Evan Levine became a director of Silvergraph International in June 2006. Mr. Levine has over 18 years of investment banking, venture capital, institutional trading, arbitrage dealing, and senior corporate management experience. Mr. Levine has served as the chief executive officer and president since September 2004 and a director since October 2002 of Adventrix Pharmaceuticals, Inc., a biopharmaceutical research and development company. From 1997 through 2001 Mr. Levine was a Managing Principal and Portfolio Manager for Brown Simpson Asset Management, LLC, a $450 million New York based private equity investment organization. In addition, Mr. Levine is the Managing Member of Mark Capital LLC, a venture capital fund specializing in technology and biotechnology investments. Mr. Levine received his B.A. in Economics and Finance from Rutgers University and has completed graduate coursework for his MBA at New York University's Stern School of Business. |